$TILE

INTERFACE INC (TILE): Results of Operations and Financial Condition

INTERFACE INC (TILE) filed an SEC Form 8-K — Results of Operations and Financial Condition. FOR IMMEDIATE RELEASE Media Contact: Christine Needles Global Corporate Communications Christine.Needles@interface.com +1 404-491-4660 Investor Contact: Bruce Hausmann Chief Financial Officer Bruce.Hausmann@interface.com +1 770-437-6802 Interface Reports Second Quarter 2026 Resul

Original reporting
Published Aug 7, 2026, 10:36 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 10:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$TILE
Bullish
high confidence
Mentioned
$TILE
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$TILEBullishHigh
01

Why it matters

Traders can reprice the stock based on the raised full-year guidance and the detailed Q3 outlook, especially the quantified margin expansion and the role of IEEPA tariff refunds.

02

Market read

A same-day earnings and guidance update with explicit Q3 and FY ranges, plus quantified margin drivers, is a direct catalyst for near-term positioning.

03

What to watch

The guidance update depends on continued backlog conversion and manufacturing efficiency; any slowdown in orders or margin normalization could pressure forward estimates despite the raised ranges.

Relevance 7/10Novelty 9/10Timing: pre-market today (SEC 8-K filed Aug 7, 2026)
alphai · Earnings readTILE · Second quarter 2026 · ended July 5, 2026

Operational execution drives strong quarter; Company raises full year guidance

Strong quarter

Second-quarter net sales increased 5.4%, GAAP operating income increased 43.9%, GAAP net income increased 57.9%, and adjusted EBITDA increased 35.2%. The Company raised full fiscal year 2026 net sales and adjusted gross profit margin guidance.

Revenue
$395.7
5.4 % y/y
AMS, three months ended 7/5/2026
$247.7
3.4 % y/y
EPS · non-GAAP
$0.88
46.7 % y/y
Q3 Fiscal Year 2026 and Full Fiscal Year 2026 outlook
Q3 Fiscal Year 2026: $370 to $380 million; Full Fiscal Year 2026: $1.455 to $1.485 billion
GM Q3 Fiscal Year 2026: 40.8% of net sales; Full Fiscal Year 2026: 40.6% of net sales

Key metrics

as reported
MetricValueq/qy/y
GAAP Net Sales, three months ended 7/5/2026GAAP$395.75.4 %
Gross Profit Margin % of Net Sales, three months ended 7/5/2026GAAP45.0 %560 bps
SG&A Expenses, three months ended 7/5/2026GAAP$103.27.5 %
SG&A Expenses % of Net Sales, three months ended 7/5/2026GAAP26.1 %53 bps
Operating Income, three months ended 7/5/2026GAAP$74.943.9 %
Net Income, three months ended 7/5/2026GAAP$51.457.9 %
Earnings per Diluted Share, three months ended 7/5/2026GAAP$0.8860.0 %
Currency-Neutral Net Sales, three months ended 7/5/2026non-GAAP$389.93.8 %
Adjusted Gross Profit Margin % of Net Sales, three months ended 7/5/2026non-GAAP45.0 %524 bps
Adjusted SG&A Expenses, three months ended 7/5/2026non-GAAP$103.110.4 %
Adjusted SG&A Expenses % of Net Sales, three months ended 7/5/2026non-GAAP26.1 %119 bps
Adjusted Operating Income, three months ended 7/5/2026non-GAAP$74.934.1 %
Adjusted Net Income, three months ended 7/5/2026non-GAAP$51.545.4 %
Adjusted Earnings per Diluted Share, three months ended 7/5/2026non-GAAP$0.8846.7 %
Adjusted EBITDA, three months ended 7/5/2026non-GAAP$87.735.2 %
GAAP Net Sales, six months ended 7/5/2026GAAP$726.78.0 %
Gross Profit Margin % of Net Sales, six months ended 7/5/2026GAAP41.9 %346 bps
SG&A Expenses, six months ended 7/5/2026GAAP$197.67.6 %
SG&A Expenses % of Net Sales, six months ended 7/5/2026GAAP27.2 %(11) bps
Operating Income, six months ended 7/5/2026GAAP$107.242.5 %
Net Income, six months ended 7/5/2026GAAP$75.064.6 %
Earnings per Diluted Share, six months ended 7/5/2026GAAP$1.2866.2 %
Currency-Neutral Net Sales, six months ended 7/5/2026non-GAAP$707.65.1 %
Adjusted Gross Profit Margin % of Net Sales, six months ended 7/5/2026non-GAAP41.9 %308 bps
Adjusted SG&A Expenses, six months ended 7/5/2026non-GAAP$197.19.4 %
Adjusted SG&A Expenses % of Net Sales, six months ended 7/5/2026non-GAAP27.1 %35 bps
Adjusted Operating Income, six months ended 7/5/2026non-GAAP$107.732.3 %
Adjusted Net Income, six months ended 7/5/2026non-GAAP$75.450.7 %
Adjusted Earnings per Diluted Share, six months ended 7/5/2026non-GAAP$1.2850.6 %
Adjusted EBITDA, six months ended 7/5/2026non-GAAP$134.432.0 %
AMS Operating Income, three months ended 7/5/2026GAAP$61.024.9 %
AMS Adjusted Operating Income, three months ended 7/5/2026non-GAAP$61.024.9 %
EAAA Operating Income, three months ended 7/5/2026GAAP$13.9334.6 %
EAAA Adjusted Operating Income, three months ended 7/5/2026non-GAAP$14.097.6 %
Cash, 7/5/2026other$81.514.3 %
Total Debt, 7/5/2026other$204.412.5 %
Total Debt Minus Cash ("Net Debt"), 7/5/2026non-GAAP$122.811.4 %
Last 12-Months Adjusted EBITDAnon-GAAP$250.5
Total Debt divided by Last 12-Months Net Incomeother1.4x
Net Debt divided by Last 12-Months Adjusted EBITDA ("Net Leverage Ratio")non-GAAP0.5x

Segments

SegmentRevenueq/qy/y
AMS, three months ended 7/5/2026Currency-Neutral Orders Increase Year-Over-Year 4.8 %$247.73.4 %
EAAA, three months ended 7/5/2026Currency-Neutral Orders Increase Year-Over-Year 6.4 %$148.08.8 %
AMS, six months ended 7/5/2026Currency-Neutral Net Sales $442.8; Currency-Neutral Net Sales change 5.6 %$443.35.7 %
EAAA, six months ended 7/5/2026Currency-Neutral Net Sales $264.8; Currency-Neutral Net Sales change 4.4 %$283.411.8 %

Q3 Fiscal Year 2026 and Full Fiscal Year 2026 outlook

  • RevenueQ3 Fiscal Year 2026: $370 to $380 million; Full Fiscal Year 2026: $1.455 to $1.485 billion
  • Gross marginQ3 Fiscal Year 2026: 40.8% of net sales; Full Fiscal Year 2026: 40.6% of net sales
  • Operating expensesQ3 Fiscal Year 2026: $100 million; Full Fiscal Year 2026: $395 million
  • Tax rateQ3 Fiscal Year 2026: 27.5%; Full Fiscal Year 2026: 26.0%
  • NoteQ3 Fiscal Year 2026 Adjusted interest & other expenses: $4 million
  • NoteQ3 Fiscal Year 2026 Fully diluted weighted average share count: 58.2 million shares
  • NoteFull Fiscal Year 2026 Adjusted interest & other expenses: $15 million
  • NoteFull Fiscal Year 2026 Capital expenditures: $60 million
  • NoteAll figures are approximate and updated guidance includes Q2 2026 IEEPA tariff refund

What drove it

  • Higher sales volumes, proactive pricing actions, favorable mix, and manufacturing efficiencies drove robust margin expansion and earnings growth.
  • Adjusted gross profit margin benefitted from 131 basis points of operational improvement and 393 basis points from $15.6 million of IEEPA tariff refunds.
  • Performance was led by Healthcare, with global billings up 19%, while Education and Corporate Office billings both increased by 5%.
  • Growth was broad-based across all regions and product categories.
  • Q2 currency-neutral orders increased 5.4% year-over-year.

Concerns

  • The Company acknowledged a dynamic and uncertain global macro environment.
  • The full fiscal year 2026 updated guidance includes the Q2 2026 IEEPA tariff refund.
  • Adjusted SG&A expenses increased due to higher sales commissions and variable compensation on increased sales and profits, and foreign currency exchange variances.
  • Risks cited include changes in foreign trade policies and tariffs, raw-material, shipping-cost, duty and tariff increases, and supply interruptions.

What to watch

  • Conversion of the robust backlog supporting continued momentum.
  • Q3 net sales outlook of $370 to $380 million.
  • Sustainability of adjusted gross profit margin following the IEEPA tariff refunds.
  • Currency-neutral order trends in AMS and EAAA.
  • Progress toward full fiscal year 2026 net sales guidance of $1.455 to $1.485 billion and adjusted gross profit margin guidance of 40.6% of net sales.

Balance sheet and cash flow

  • Cash: $81.5 at 7/5/2026, compared with $71.3 at 12/28/2025
  • Total Debt: $204.4 at 7/5/2026, compared with $181.6 at 12/28/2025
  • Total Debt Minus Cash ("Net Debt"): $122.8 at 7/5/2026, compared with $110.3 at 12/28/2025
  • Last 12-Months Adjusted EBITDA: $250.5
  • Net Debt divided by Last 12-Months Adjusted EBITDA ("Net Leverage Ratio"): 0.5x

Analysis

Interface reported second-quarter GAAP net sales of $395.7, up 5.4%, while currency-neutral net sales were $389.9, up 3.8%. Currency-neutral orders increased 5.4% year-over-year. Management described growth as broad-based across regions and product categories, with Healthcare global billings up 19% and Education and Corporate Office billings each up 5%.

Both reporting segments grew. AMS net sales were $247.7, up 3.4%, and currency-neutral orders increased 4.8%. EAAA net sales were $148.0, up 8.8%, with currency-neutral net sales of $142.2, up 4.5%, and currency-neutral orders up 6.4%. EAAA GAAP operating income increased to $13.9 from $3.2, while AMS GAAP operating income increased to $61.0 from $48.8.

Margin and earnings expansion outpaced sales growth. GAAP gross profit margin was 45.0%, compared with 39.4%, and adjusted gross profit margin was 45.0%, compared with 39.8%. The Company attributed adjusted margin improvement to favorable price/mix, lower manufacturing costs on higher sales volumes, manufacturing efficiency initiatives, and IEEPA tariff refunds. Adjusted gross profit margin included 131 basis points of operational improvement and 393 basis points from $15.6 million of IEEPA tariff refunds. GAAP operating income increased 43.9% to $74.9, GAAP net income increased 57.9% to $51.4, and adjusted EBITDA increased 35.2% to $87.7.

The balance sheet metrics show cash of $81.5 and total debt of $204.4 at July 5, 2026. Net debt was $122.8, and the reported net leverage ratio was 0.5x. The release reported no dividends, share repurchases, operating cash flow, or free cash flow. Full fiscal year 2026 capital expenditures guidance remained $60 million.

Interface raised full fiscal year 2026 net sales guidance to $1.455 to $1.485 billion and adjusted gross profit margin guidance to 40.6% of net sales. The outlook also calls for $395 million of adjusted SG&A expenses, $15 million of adjusted interest and other expenses, and a 26.0% adjusted effective income tax rate. For Q3 fiscal year 2026, the Company guided to net sales of $370 to $380 million and adjusted gross profit margin of 40.8% of net sales, while acknowledging a dynamic and uncertain global macro environment.

Management, verbatim

We delivered strong second quarter results, reflecting continued momentum and disciplined execution across the business.

Laurel Hurd, CEO of Interface

This growth was broad-based across all regions and product categories, underscoring the strength of our diversified portfolio and the benefits of our One Interface strategy.

Laurel Hurd, CEO of Interface

We are raising our full year guidance based on strong first half performance and a robust backlog supporting continued momentum.

Bruce Hausmann, CFO of Interface

Not in the filing

stated, not guessed
  • Prior-quarter comparisons for consolidated and segment metrics
  • Operating cash flow
  • Free cash flow
  • Share repurchases
  • Dividend declarations or payments
  • Adjusted gross profit dollar amount
  • GAAP effective income tax rate
  • GAAP and adjusted diluted weighted average share count for the reported period
  • Previous-release outlook for comparison against actual results

AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

The 8-K (Item 2.02) attaches Interface’s Q2 2026 results press release and provides updated Q3 and full-year fiscal guidance.

Company-level read

Ticker impact

$TILEBullishHigh confidence
Context

Interface (TILE) reported Q2 results and raised full-year guidance, citing margin expansion and IEEPA tariff refunds plus a robust backlog.

Expected impact

Likely positive bias for the stock as guidance is increased and margin drivers (pricing, manufacturing efficiency, tariff refunds) are quantified.

Evidence & confidence

The filing includes specific Q3 and full-year guidance updates, with multiple quantified drivers (net sales, gross margin, adjusted EPS, and IEEPA tariff refunds) that are directly actionable for traders and analysts.

Market effects

Signals improving profitability and demand momentum in commercial flooring and sustainability-related construction inputs, potentially supporting sentiment for peers with similar end markets.

Mentions broad-based growth across regions, which can reduce regional concentration risk for the sector narrative.

IEEPA tariff refunds highlight policy-driven variability in margins, which may keep macro and trade-policy sensitivity elevated for the group.

Counterpoint

Tariff refunds and favorable mix may be less repeatable than underlying operational improvements, so the guidance raise could partially reflect one-time or timing effects.

Key entities

  • Interface, Inc.

    Nasdaq-listed flooring and sustainability company reporting Q2 2026 results and raising full-year guidance.

  • Laurel Hurd

    CEO quoted on strong Q2 performance and broad-based growth across regions and product categories.

  • Bruce Hausmann

    CFO quoted on margin drivers and the decision to raise full-year guidance.

Every TILE earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$TILEMedAI 8/10

Interface (TILE) Q2 2026 Earnings Call Transcript

Interface (TILE) reported Q2 2026 net sales of $395.7 million, up 5.4% (3.8% currency-neutral). Adjusted gross margin rose to 45.0% with a $15.6 million tariff refund. Adjusted EPS was $0.88, up 47%, and adjusted EBITDA was $87.7 million. Full-year 2026 revenue guidance is $1.455B to $1.485B.

$TILEMed

Interface, Inc. Q2 2026 Earnings Call Summary

Interface, Inc. reported 4% currency-neutral Q2 2026 net sales growth on its One Interface strategy. Healthcare delivered 19% global billings growth. The company raised full-year 2026 guidance, citing 22% backlog growth and expects ~39% second-half gross margin run rate. Q2 included a $15.6M IEEPA tariff refund benefit (~$0.19 EPS).

$TILEMedAI 8/10

Why Is Interface (TILE) Stock Rocketing Higher Today

Interface (NASDAQ: TILE) shares rose after Q2 results beat expectations. Adjusted EPS was $0.88, about 38% above estimates, with adjusted operating margin up to 18.9% from 13.9%. Revenue was $395.7M (+5.4% YoY). Q3 sales guidance of $370M-$380M was slightly below consensus, while full-year sales was raised to $1.455B-$1.485B. Stock closed at $38.37, up 9.3%.

$TILEMedAI 8/10

Interface: Q2 Earnings Snapshot

Interface Inc. (TILE) reported Q2 net income of $51.4 million, or 88 cents per share, on revenue of $395.7 million. For the quarter ending September, the company forecast revenue of $370 million to $380 million. Full-year revenue guidance is $1.46 billion to $1.49 billion.